Michelle Dawson posts

Post published on Bluesky on 1 Nov 2023 12:26

Bluesky DOI work crossref External link integrated into the post Autism terms

1 integrated reply by Michelle Dawson

1 Nov 2023 12:32

Note: in all the other age groups (20-49 years, 50-59 years, 60-69 years, 70-79 years, 80+ years), autism does not appear among the top 20 most common combinations--see Figure 3

View reply on Bluesky

Structured cited links

1 cited resource

DOI work Fetched Post crossref

Jonathan Valabhji, Emma Barron, Adrian Pratt, Nasrin Hafezparast, Rupert Dunbar-Rees, Ellie Bragan Turner, Kate Roberts, Jacqueline Mathews, et al. (2024). Prevalence of multiple long-term conditions (multimorbidity) in England: a whole population study of over 60 million people. Journal of the Royal Society of Medicine, 117(3), 104-117. SAGE Publications.

Publication date
31 Oct 2023
Identifier
10.1177/01410768231206033
Authors
Jonathan Valabhji, Emma Barron, Adrian Pratt, Nasrin Hafezparast, Rupert Dunbar-Rees, Ellie Bragan Turner, Kate Roberts, Jacqueline Mathews, Robbie Deegan, Victoria Cornelius, Jason Pickles, Gary Wainman, Chirag Bakhai, Desmond G Johnston, Edward W Gregg, Kamlesh Khunti
Source
Journal of the Royal Society of Medicine
Details
117(3), 104-117
Reference type
article
Publisher
SAGE Publications
Metadata source
crossref

Abstract

Objectives To determine the prevalence of multiple long-term conditions (MLTC) at whole English population level, stratifying by age, sex, socioeconomic status and ethnicity. Design A whole population study. Setting Individuals registered with a general practice in England and alive on 31 March 2020. Participants 60,004,883 individuals. Main outcome measures MLTC prevalence, defined as two or more of 35 conditions derived from a number of national patient-level datasets. Multivariable logistic regression was used to assess the independent associations of age, sex, ethnicity and deprivation decile with odds of MLTC. Results The overall prevalence of MLTC was 14.8% (8,878,231), varying from 0.9% (125,159) in those aged 0–19 years to 68.2% (1,905,979) in those aged 80 years and over. In multivariable regression analyses, compared with the 50–59 reference group, the odds ratio was 0.04 (95% confidence interval (CI): 0.04–0.04; p < 0.001) for those aged 0–19 years and 10.21 (10.18–10.24; p < 0.001) for those aged 80 years and over. Odds were higher for men compared with women, 1.02 (1.02–1.02; p < 0.001), for the most deprived decile compared with the least deprived, 2.26 (2.25–2.27; p < 0.001), and for Asian ethnicity compared with those of white ethnicity, 1.05 (1.04–1.05; p < 0.001). Odds were lower for black, mixed and other ethnicities (0.94 (0.94–0.95) p < 0.001, 0.87 (0.87–0.88) p < 0.001 and 0.57 (0.56–0.57) p < 0.001, respectively). MLTC for persons aged 0–19 years were dominated by asthma, autism and epilepsy, for persons aged 20–49 years by depression and asthma, for persons aged 50–59 years by hypertension and depression and for those aged 60 years and older, by cardiometabolic factors and osteoarthritis. There were large numbers of combinations of conditions in each age group ranging from 5936 in those aged 0–19 years to 205,534 in those aged 80 years and over. Conclusions While this study provides useful insight into the burden across the English population to assist health service delivery planning, the heterogeneity of MLTC presents challenges for delivery optimisation.

Study authors in this cited reference